A lung-targeting britannin-lipid nanoparticle formulation and use thereof
This technology is a novel lung-targeting britannin-lipid nanoparticle formulation designed to effectively treat acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) by inhibiting lung inflammation.
Background:
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe lung conditions characterized by intense...
Published: 6/12/2026
|
Inventor(s): Yamin Li, Qinghe Meng, Daping Fan
Keywords(s): acute lung injury, drug delivery, Technologies
Category(s): Campus > Upstate Medical University, Technology Classifications > Drug Delivery
|
Lipid nanoparticles for targeted delivery of therapeutic agents in acute lung injury
This technology uses lung-targeting lipid nanoparticles to deliver a combination of anti-inflammatory and immune-modulating drugs directly to the lungs, offering a more effective and targeted treatment for acute lung injury and acute respiratory distress syndrome.
Background:
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)...
Published: 4/2/2026
|
Inventor(s): Yamin Li, Yuqin Men, Robert Cooney, Qinghe Meng
Keywords(s): acute lung injury, anti-inflammatory therapeutic, drug delivery, Technologies
Category(s): Campus > Upstate Medical University, Technology Classifications > Drug Delivery
|
Click-Chemistry Enabled Polyhydroxyalkanoate Polymers
Synthesis of PHAs using a modified bacterial strain and click chemistry.
Background: Polyhydroxyalkanoates (PHAs) are biodegradable plastics produced by microorganisms that can be used as substitutes for non-biodegradable, petroleum-based plastics. Because PHAs are produced by microorganisms, the monomer unit composition can’t always be controlled,...
Published: 1/30/2026
|
Inventor(s): Christopher Nomura, Atahualpa Pinto
Keywords(s): 3D printing, acute lung injury, TAF, Technologies
Category(s): Campus > SUNY Environmental Science & Forestry, Technology Classifications > Environment
|